Taiho Oncology, Inc.
Carolyn Keller has extensive experience in the pharmaceutical industry, specifically in sales operations and analytics. Carolyn began their career at Sequus Pharmaceuticals in 1996 as a Sr. Sales Analyst and continued in a similar role at Alza Corporation from 1997 to 2000. In 2000, they joined C3i as a Business Analyst and later moved to Dunn and Bradstreet as a Consultant from 2002 to 2003. In 2003, Keller joined Wyeth as a Manager, Global Data before transitioning to ImClone Systems in 2004 as a Sr. Manager, Sales Analytics. Carolyn then worked at Allos Therapeutics as a Director, Sales Operations from 2009 to 2012. In 2012, they joined Spectrum Pharmaceuticals in a similar role for a brief period of time. Keller continued to advance their career by joining Sucampo Pharmaceuticals, Inc. in 2013 as a Director, Sales Operations, and later moved to Taiho Oncology, Inc. in the same year where they currently serve as a Sr. Director, Sales Operations.
Carolyn Keller attended Carroll College from 1983 to 1988. However, no information regarding the degree or field of study pursued by Carolyn during their time at the college is available.
This person is not in any teams
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com